Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease
Crossref DOI link: https://doi.org/10.1371/journal.pntd.0004014
Published Online: 2015-09-22
Update policy: https://doi.org/10.1371/journal.pntd.corrections_policy
Riley, Jennifer
Brand, Stephen
Voice, Michael
Caballero, Ivan
Calvo, David
Read, Kevin D.
Version of Record valid from 2015-09-22